Natco Pharma shares fell 6.7% to ₹1,087.30 on the BSE on Wednesday, after the company said the Delhi High Court had allowed an application of U.S.-bas
from The Hindu - Home https://ift.tt/3yw3TRZ
via IFTTT
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
Khyber (Pakistan): Vehicular traffic to and from Torkham was restored after remaining closed for several hours owing to a protest by the Kh...
No comments:
Post a Comment